Lisata Therapeutics, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
LSTA on Nasdaq
Location
110 Allen Road, Second Floor, Basking Ridge, NJ

There are no Buy or Sell transactions made by insiders since 12/22/2023

Lisata Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Erkki Ruoslahti Director $3.56M Jan 9, 2023
Steven S. Myers Director $668K Jan 10, 2022
Michael H. Davidson Director $627K Jan 10, 2022
David J. Mazzo President & CEO, Director $621K Oct 1, 2024
Anne Clem Whitaker Director $546K Jan 10, 2022
Todd Girolamo CLO, SVP of Corp Dev $481K Jan 13, 2022
Peter G. Traber Director $446K Jan 10, 2022
Kristen K. Buck EVP, R&D and CMO $184K Oct 1, 2024
Mohammad Azab Director $175K Jan 9, 2024
Steven M. Klosk Director $148K Jan 9, 2024
Gregory B. Brown Director $148K Jan 9, 2024
Cynthia Louise Flowers Director $147K Jan 9, 2024
Heidi Henson Director $118K Jan 9, 2024
David Slack President & CBO, Director $61.7K Jan 9, 2023
James Nisco SVP, Fin/Treas, Chief Actg Off $38K Oct 1, 2024

Recent Insider Transactions by Companies or Individuals for Lisata Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.